On the other hand, for the HCC patients with AFP levels between 20 and 400 ng/mL, the extent of malignancy is higher than that in AFP-negative patients, and long-term prognosis after resection need to be further studied; our group will continue to follow up these patients. This evidence concerns the gene AFP and hepatocellular carcinoma.